Background Alternative treatments for visceral leishmaniasis (VL) are required in East Africa.
Paromomycin sulphate (PM) has been shown to be efficacious for VL treatment in India. …

Background Visceral leishmaniasis (VL) is a major health problem in developing countries.
The untreated disease is fatal, available treatment is expensive and often toxic, and drug …

Background Anti-leishmanial drug regimens that include a single dose AmBisome® could
be suitable for eastern African patients with symptomatic visceral leishmaniasis (VL) but the …

Introduction: Cervical cancer is the second most common form of cancer for women in
Ethiopia. Using a single-visit approach to prevent cervical cancer, the Addis Tesfa (New Hope) …

Background Parasites' evolution in response to parasite-targeted control strategies, such as
vaccines and drugs, is known to be influenced by their population genetic structure. The aim …

… in patients with VL and contributes to impaired T cell responses. We recruited patients with
VL … levels of L-arginine in the plasma and decreased expression levels of CD3ζ in T cells. …

… Our results show that CD4 + T cell counts were significantly lower and the parasite load in
the spleen was significantly higher in co-infected patients. Moreover, our results demonstrate …

Human pose estimation localizes body keypoints to accurately recognizing the postures of
individuals given an image. This step is a crucial prerequisite to multiple tasks of computer …

Background/Objectives Visceral leishmaniasis (VL) caused by Leishmania donovani is a
major health problem in Ethiopia. Parasites in disparate regions are transmitted by different …

Background: In Ethiopia, the publicly funded antiretroviral treatment (ART) program was
started in 2005. Two hundred seventy-five thousand patients were enrolled in the national ART …